Jennifer Wheler, MD, Consulting CMO

Jennifer has over 20 years of experience as an oncologist specializing in early drug development in academia and industry - as an Associate Professor at MD Anderson Cancer Center, a Clinical Program Leader at The Novartis Institutes for BioMedical Research (NIBR) and a Chief Medical Officer in small biotech. At MD Anderson she was the Principal Investigator on over 30 Phase 1/2 trials and co-author of 145 peer-reviewed publications. In industry, Jennifer has built and led teams to early milestones including anti-PD-L1 antibody FAZ053, the first Novartis immunotherapy compound to achieve clinical proof-of-concept in dose escalation, HER2-TLR7/8 immune stimulatory antibody conjugate NJH395 (Novartis), and bifunctional EGFR/TGFb Trap fusion protein BCA101 (Bicara Therapeutics).

Jennifer completed a breast medical oncology fellowship at Memorial Sloan Kettering, a medical oncology fellowship at Yale Cancer Center and an internal medicine residency at Columbia University / NewYork-Presbyterian Hospital. She earned an M.D. from Cornell Medical College and an A.B. in Art History from Princeton University.

She is the Founder of Collage, a nonprofit that provides personalized art programs for patients living with cancer.